GE HealthCare to acquire Sofie Biosciences for $945M
The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive drugs used in PET imaging.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.